Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Immunologic Research|July 11, 2001
VEGF as a mediator of tumor-associated immunodeficiencyJ E Ohm, D P CarboneThe Journal of Infusional Chemotherapy|January 1, 1995
Taxol plus radiation for head and neck cancerD I Rosenthal, D P CarboneHybridoma|April 1, 1995
Mutant oncopeptide immunization induces CTL specifically lysing tumor cells endogenously expressing the corresponding intact mutant p53I F Ciernik, J Berzofsky, D P CarboneJournal of Immunological Methods|February 5, 1996
In vivo cytotoxicity assay for assessing immunityD C Tang, A F Gazdar, D P CarboneCancer Gene Therapy|March 1, 1994
Butyrate-inducible and tumor-restricted gene expression by adenovirus vectorsD C Tang, S A Johnston, D P CarboneCellular Immunology|May 25, 1996
Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hostsD I Gabrilovich, I F Ciernik, D P CarboneJournal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancerD I Gabrilovich, H T Cunningham, D P CarboneJournal of Oncology Research and Therapy|August 30, 2024
Vaping, Smoking and Lung Cancer RiskM A Bittoni, D P Carbone, R E HarrisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant-specific cytotoxic T lymphocytesI F Ciernik, J A Berzofsky, D P CarbonePageof 9